Detecting Epidermal Growth Factor Receptor Tumor Activity In Vivo During Cetuximab Therapy of Murine Gliomas

Academic Radiology

Volumn 17, Issue 1, 2010, Pages 7-17

  Gibbs Strauss, Summer L ^a,e   Samkoe, Kimberley S ^a   O'Hara, Julia A ^a   Davis, Scott C ^a   Hoopes, P Jack ^a,b   Hasan, Tayyaba ^c,d   Pogue, Brian W ^a,b,c  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE IMAGING; GLIOMA; GLIOSARCOMA; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 71049173751     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.07.027     Document Type: Article

References (20)

1. Sathornsumetee S., and Rich J.N. New treatment strategies for malignant glioma. Exp Rev Anticancer Ther 6 (2006) 1087-1104
2. Sathornsumetee S., Reardon D.A., Desjardins A., et al. Molecularly targeted therapy for malignant glioma. Cancer 110 (2007) 13-24
3. Mischel P.S., and Cloughesy T.F. Targeted molecular therapy of GBM. Brian Pathol 13 (2003) 52-61
4. Krishnan S., Rao R.D., James C.D., et al. Combination of epidermal growth factor targeted therapy with radiation therapy for malignant glioma. Front Biosci 8 (2003) e1-e13
5. Halatsch M.E., Schmidt U., Behnke-Mursch J., et al. Epidermal growth factor receptor inhibitors for the treatment of glioblastoma multiforme and other malignant brain tumors. Cancer Treat Rev 32 (2006) 74-89
6. Marshall J. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer 107 (2006) 1207-1218
7. Harding J., and Burtness B. Cetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibody. Drugs Today 41 (2005) 107-127
8. Eller J.L., Longo S.L., Hicklin D.J., et al. Activity of anti-epidermal growth factor receptor monocolonal antibody C225 against glioblastoma multiforme. Neurosurgery 51 (2002) 1005-1014
9. Eller J.L., Longo S.L., Kyle M.M., et al. Anti-epidermal growth factor receptor monocolonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Neurosurgery 56 (2005) 155-162
10. Sokolov K., Nida D., Descour M., et al. Molecular optical imaging of therapeutic targets of cancer. Adv Cancer Res 96 (2007) 299-344
11. Moore A., Marecos E., Simonova M., et al. Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis. Microvasc Res 56 (1998) 145-153
12. Davis S.C., Pogue B.W., Springett R., et al. Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue. Rev Sci Instrum (2008) 79 064302
13. Ntziachristos V., Turner G., Dunham J., et al. Planar fluorescence imaging using normalized data. J Biomed Optics 10 (2005) 064007-1-064007-18
14. Raben D., Helfrich B., Chan D.C., et al. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res 11 (2005) 795-805
15. Luo F.R., Yang Z., Dong H., et al. Correlation of pharmacokinetics with the antitumor activity of cetuximab in nude mice bearing the GEO human colon carcinoma xenograft. Cancer Chemother Pharmacol 56 (2005) 455-464
16. Gauthier-Balin D., Delord J.P., Rochaix P., et al. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different levels of EGFR. Cancer Chemother Pharmacol 57 (2006) 709-718
17. Kovar J.L., Johnson M.A., Volcheck W.M., et al. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 169 (2006) 1415-1426
18. Pogue B.W., Davis S.C., Song X., et al. Image analysis methods for diffuse optical tomography. J Biomed Optics 11 (2006) 033001-1-033001-16
19. Kim E.S., Khuri F.R., and Herbst R.S. Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol 13 (2001) 506-513
20. Baselga J. The EGFR as a target for anticancer therapy-focus on cetuximab. Eur J Cancer 37 (2001) S16-S22